Insmed Inc (INSM) Reports Q3 2022 Financial Results
Insmed Inc (INSM) announced its financial results for the period ending Q3 2022.
Key Financial Highlights:
Revenue: 16395
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 416078
targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint across Europe and in Japan. For more information, visit www.insmed.com. Forward-looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties. “Forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995
📋 INSMED INCORPORATED (INSM) - Financial Results
Filing Date: 2022-08-04
Accepted: 2022-08-04 07:30:27
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: